{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:03:02Z","timestamp":1770292982510,"version":"3.49.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2014,4,23]]},"DOI":"10.1001\/jama.2014.3325","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T22:31:19Z","timestamp":1398205879000},"page":"1618","source":"Crossref","is-referenced-by-count":11,"title":["Acetazolamide for Pseudotumor Cerebri"],"prefix":"10.1001","volume":"311","author":[{"given":"Jonathan C.","family":"Horton","sequence":"first","affiliation":[{"name":"Beckman Vision Center, Department of Ophthalmology, University of California, San Francisco2Departments of Neurology and Physiology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1861775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T18:22:39Z","timestamp":1481826159000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2014.3325"}},"subtitle":["Evidence From the NORDIC Trial"],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":0,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,4,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2014.3325","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}